Infinium Pharmachem Limited (NSE:INFINIUM)

India flag India · Delayed Price · Currency is INR
212.00
+4.50 (2.17%)
Apr 29, 2026, 2:39 PM IST
-29.57%
Market Cap 3.30B
Revenue (ttm) 1.57B
Net Income (ttm) 93.40M
Shares Out 15.58M
EPS (ttm) 6.07
PE Ratio 34.95
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 4,200
Open 214.00
Previous Close 207.50
Day's Range 212.00 - 215.95
52-Week Range 189.40 - 337.00
Beta 0.28
RSI 52.64
Earnings Date May 22, 2026

About Infinium Pharmachem

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and inte... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2003
Employees 144
Stock Exchange National Stock Exchange of India
Ticker Symbol INFINIUM
Full Company Profile

Financial Performance

In fiscal year 2025, Infinium Pharmachem's revenue was 1.56 billion, an increase of 14.78% compared to the previous year's 1.36 billion. Earnings were 81.45 million, a decrease of -27.93%.

Financial Statements

News

There is no news available yet.